In patients with type 2 diabetes (T2DM), it has been reported that by 9 months of follow-up 7% of patients on recently initiated insulin or sulphonylurea treatment will have experienced severe hypoglycaemia (hypoglycaemia needing external assistance) [3]. Here, INS is linked to type 2 diabetes mellitus.